Literature DB >> 17709470

Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activity.

Winslow S Caughey1, Suzette A Priola, David A Kocisko, Lynne D Raymond, Anne Ward, Byron Caughey.   

Abstract

Cyclic tetrapyrroles are among the most potent compounds with activity against transmissible spongiform encephalopathies (TSEs; or prion diseases). Here the effects of differential sulfonation and metal binding to cyclic tetrapyrroles were investigated. Their potencies in inhibiting disease-associated protease-resistant prion protein were compared in several types of TSE-infected cell cultures. In addition, prophylactic antiscrapie activities were determined in scrapie-infected mice. The activity of phthalocyanine was relatively insensitive to the number of peripheral sulfonate groups but varied with the type of metal bound at the center of the molecule. The tendency of the various phthalocyanine sulfonates to oligomerize (i.e., stack) correlated with anti-TSE activity. Notably, aluminum(III) phthalocyanine tetrasulfonate was both the poorest anti-TSE compound and the least prone to oligomerization in aqueous media. Similar comparisons of iron- and manganese-bound porphyrin sulfonates confirmed that stacking ability correlates with anti-TSE activity among cyclic tetrapyrroles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709470      PMCID: PMC2151414          DOI: 10.1128/AAC.01599-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  A solid-phase assay for identification of modulators of prion protein interactions.

Authors:  Laura Maxson; Caíne Wong; Lynn M Herrmann; Byron Caughey; Gerald S Baron
Journal:  Anal Biochem       Date:  2003-12-01       Impact factor: 3.365

2.  Inhibition of protease-resistant prion protein accumulation in vitro by curcumin.

Authors:  Byron Caughey; Lynne D Raymond; Gregory J Raymond; Laura Maxson; Jay Silveira; Gerald S Baron
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 3.  Prions and their partners in crime.

Authors:  Byron Caughey; Gerald S Baron
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

Review 4.  Structure and biodistribution relationships of photodynamic sensitizers.

Authors:  R W Boyle; D Dolphin
Journal:  Photochem Photobiol       Date:  1996-09       Impact factor: 3.421

5.  Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen.

Authors:  R Race; M Oldstone; B Chesebro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein.

Authors:  D Vilette; O Andreoletti; F Archer; M F Madelaine; J L Vilotte; S Lehmann; H Laude
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

7.  New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Authors:  David A Kocisko; Gerald S Baron; Richard Rubenstein; Jiancao Chen; Salomon Kuizon; Byron Caughey
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Prophylactic and therapeutic effects of phthalocyanine tetrasulfonate in scrapie-infected mice.

Authors:  Suzette A Priola; Anne Raines; Winslow Caughey
Journal:  J Infect Dis       Date:  2003-08-14       Impact factor: 5.226

9.  Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones.

Authors:  R E Race; B Caughey; K Graham; D Ernst; B Chesebro
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein.

Authors:  Eui-Nam Lee; Hyun-Ju Cho; Choong-Hwan Lee; Daekyun Lee; Kwang Chul Chung; Seung R Paik
Journal:  Biochemistry       Date:  2004-03-30       Impact factor: 3.162

View more
  11 in total

1.  A survey of antiprion compounds reveals the prevalence of non-PrP molecular targets.

Authors:  Guillaume Poncet-Montange; Susan J St Martin; Olga V Bogatova; Stanley B Prusiner; Brian K Shoichet; Sina Ghaemmaghami
Journal:  J Biol Chem       Date:  2011-05-24       Impact factor: 5.157

2.  Binding Modes of Phthalocyanines to Amyloid β Peptide and Their Effects on Amyloid Fibril Formation.

Authors:  Ariel A Valiente-Gabioud; Dietmar Riedel; Tiago F Outeiro; Mauricio A Menacho-Márquez; Christian Griesinger; Claudio O Fernández
Journal:  Biophys J       Date:  2018-03-13       Impact factor: 4.033

3.  Toward the discovery of effective polycyclic inhibitors of alpha-synuclein amyloid assembly.

Authors:  Gonzalo R Lamberto; Valentina Torres-Monserrat; Carlos W Bertoncini; Xavier Salvatella; Markus Zweckstetter; Christian Griesinger; Claudio O Fernández
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

Review 4.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

5.  Structure of the flexible amino-terminal domain of prion protein bound to a sulfated glycan.

Authors:  Lara M Taubner; Ewa A Bienkiewicz; Valérie Copié; Byron Caughey
Journal:  J Mol Biol       Date:  2009-11-10       Impact factor: 5.469

6.  Vaccination with Prion Peptide-Displaying Polyomavirus-Like Particles Prolongs Incubation Time in Scrapie-Infected Mice.

Authors:  Martin Eiden; Alma Gedvilaite; Fabienne Leidel; Rainer G Ulrich; Martin H Groschup
Journal:  Viruses       Date:  2021-04-30       Impact factor: 5.048

7.  A Medicinal Herb Scutellaria lateriflora Inhibits PrP Replication in vitro and Delays the Onset of Prion Disease in Mice.

Authors:  Martin Eiden; Fabienne Leidel; Barbara Strohmeier; Christine Fast; Martin H Groschup
Journal:  Front Psychiatry       Date:  2012-02-17       Impact factor: 4.157

8.  Role of Tyr-39 for the Structural Features of α-Synuclein and for the Interaction with a Strong Modulator of Its Amyloid Assembly.

Authors:  Oscar Palomino-Hernandez; Fiamma A Buratti; Pamela S Sacco; Giulia Rossetti; Paolo Carloni; Claudio O Fernandez
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

9.  Prion Strains Differ in Susceptibility to Photodynamic Oxidation.

Authors:  Marie Kostelanska; Karel Holada
Journal:  Molecules       Date:  2022-01-18       Impact factor: 4.411

10.  Pharmacological chaperone for the structured domain of human prion protein.

Authors:  Andrew J Nicoll; Clare R Trevitt; M Howard Tattum; Emmanuel Risse; Emma Quarterman; Amaurys Avila Ibarra; Connor Wright; Graham S Jackson; Richard B Sessions; Mark Farrow; Jonathan P Waltho; Anthony R Clarke; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.